A report from the Patented Medicine Prices Review Board (PMPRB) compares generic drug prices in Canada with those of other industrialized countries.
December 16, 2014
Bill C-8, the Combatting Counterfeit Products Act received Royal Assent on December 9, 2014.
December 12, 2014
On September 30, 2014, Health Canada took action to ban the import of finished drug products and active pharmaceutical ingredients.
December 03, 2014
Intellectual Property professionals, and owners of intellectual property (IP) rights, generally agree on the important value of patents.
December 02, 2014
Apotex Inc. (“Apotex”) had commenced an action for damages, including punitive damages, against Health Canada for its failure to issue a Notice of Compliance.
November 28, 2014
The Nagoya Protocol on Access and Benefit-sharing (the Protocol), adopted in 2010 by the parties to the Convention on Biological Diversity (the Convention), entered into force in October 2014.
November 19, 2014
The Supreme Court of Canada has refused Teva’s application for leave to appeal the decision of the Federal Court of Appeal.
November 17, 2014
There have been a number of notable developments in recent weeks in respect of patent utility law in Canada.
November 14, 2014
On October 23, 2014, the Canadian government introduced an omnibus budget bill.
November 10, 2014
Bill C-17, An Act to Amend the Food and Drugs Act, has now passed through Parliament and was given Royal Assent on November 6, 2014.
November 07, 2014
Try searching our global site instead